Exane Asset Management’s Takeda Pharmaceutical TAK Stock Holding History

Exane Asset Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-39,458	Closed	-$718K	–	25
2020 Q4	$718K	Sell	39,458 -13,634	-26%	-$239K	0.51%	15
2020 Q3	$947K	Hold	53,092	–	–	0.62%	17
2020 Q2	$952K	Hold	53,092	–	–	0.98%	14
2020 Q1	$806K	Hold	53,092	–	–	1.57%	8
2019 Q4	$1.05M	Sell	53,092 -9,546	-15%	-$183K	1.29%	18
2019 Q3	$1.08M	Sell	62,638 -217,362	-78%	-$3.76M	0.83%	19
2019 Q2	$4.96M	Sell	280,000 -150,369	-35%	-$2.74M	2.2%	15
2019 Q1	$8.77M	Sell	430,369 -503,097	-54%	-$10.1M	4.27%	8
2018 Q4	$15.7M	Buy	+933,466	New	+$15.8M	9.21%	3

Other funds holding TAK

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Exane Asset Management's TAK Position: Q1 2021 in Review

Exane Asset Management sold out of Takeda Pharmaceutical (TAK) in Q1 2021, closing a stake of 39,458 shares — an estimated $718K sold.

Exane Asset Management first reported a position in TAK in Q4 2018 and held it in 9 quarters. The position peaked at $15.7M in Q4 2018. 316 funds tracked by Wall St. Rank hold TAK as of Q1 2021.

Exane Asset Management reported no remaining Takeda Pharmaceutical position as of Q1 2021 after selling out during the quarter.
Exane Asset Management sold 39,458 Takeda Pharmaceutical shares in Q1 2021, an estimated $718K.
Exane Asset Management first reported a position in Takeda Pharmaceutical in Q4 2018 and held it in 9 quarters.
Exane Asset Management's Takeda Pharmaceutical position peaked at $15.7M in Q4 2018.
316 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2021.

Based on Exane Asset Management's 13F filing for Q1 2021, filed 21 Apr 2021.